Professor Chris J Packard, Professor of Vascular Biochemistry, University of Glasgow, UK, contrasts the emerging paradigm for the impact of triglyceride rich lipoproteins and Lp(a) on the atherogenic process with that of LDL-C, and discusses remaining gaps in understanding.
Educational partners and supporters
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
